These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32679691)

  • 1. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.
    Zettl F; Meister TL; Vollmer T; Fischer B; Steinmann J; Krawczyk A; V'kovski P; Todt D; Steinmann E; Pfaender S; Zimmer G
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32679691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.
    Oguntuyo KY; Stevens CS; Hung CT; Ikegame S; Acklin JA; Kowdle SS; Carmichael JC; Chiu HP; Azarm KD; Haas GD; Amanat F; Klingler J; Baine I; Arinsburg S; Bandres JC; Siddiquey MNA; Schilke RM; Woolard MD; Zhang H; ; Duty AJ; Kraus TA; Moran TM; Tortorella D; Lim JK; Gamarnik AV; Hioe CE; Zolla-Pazner S; Ivanov SS; Kamil JP; Krammer F; Lee B
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response.
    Ostadgavahi AT; Booth R; Sisson G; McMullen N; Warhuus M; Robertson P; Miller M; Allen WC; El Sherif M; Brownlie R; Falzarano D; Richardson CD
    J Infect Dev Ctries; 2021 May; 15(5):653-656. PubMed ID: 34106888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
    Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
    Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.
    Li H; Zhao C; Zhang Y; Yuan F; Zhang Q; Shi X; Zhang L; Qin C; Zheng A
    Emerg Microbes Infect; 2020 Dec; 9(1):2269-2277. PubMed ID: 32990161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection.
    Jamieson TR; Poutou J; Marius R; He X; Rezaei R; Azad T; Ilkow CS
    J Vis Exp; 2021 Jun; (172):. PubMed ID: 34152313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.
    Hu J; Gao Q; He C; Huang A; Tang N; Wang K
    Genes Dis; 2020 Dec; 7(4):551-557. PubMed ID: 32837985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and Standardized Pseudovirus Neutralization Assay for COVID-19.
    Izac JR; Kwee EJ; Gaigalas A; Wang L
    Methods Mol Biol; 2024; 2779():259-271. PubMed ID: 38526789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies.
    Lester S; Harcourt J; Whitt M; Al-Abdely HM; Midgley CM; Alkhamis AM; Aziz Jokhdar HA; Assiri AM; Tamin A; Thornburg N
    Access Microbiol; 2019; 1(9):e000057. PubMed ID: 32974558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Four SARS-CoV-2 Neutralization Assays.
    Riepler L; Rössler A; Falch A; Volland A; Borena W; von Laer D; Kimpel J
    Vaccines (Basel); 2020 Dec; 9(1):. PubMed ID: 33379160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials.
    Sholukh AM; Fiore-Gartland A; Ford ES; Hou Y; Tse LV; Lempp FA; Kaiser H; Saint Germain R; Bossard E; Kee JJ; Diem K; Stuart AB; Rupert PB; Brock C; Buerger M; Doll MK; Randhawa AK; Stamatatos L; Strong RK; McLaughlin C; Jerome KR; Baric RS; Montefiori D; Corey L
    medRxiv; 2020 Dec; ():. PubMed ID: 33330875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein.
    Tandon R; Mitra D; Sharma P; McCandless MG; Stray SJ; Bates JT; Marshall GD
    Sci Rep; 2020 Nov; 10(1):19076. PubMed ID: 33154514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay.
    Almahboub SA; Algaissi A; Alfaleh MA; ElAssouli MZ; Hashem AM
    Front Microbiol; 2020; 11():2020. PubMed ID: 33013745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2-Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
    Cai Z; Kalkeri R; Zhu M; Cloney-Clark S; Haner B; Wang M; Osman B; Dent D; Feng SL; Longacre Z; Glenn G; Plested JS
    Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay.
    Tolah AMK; Sohrab SS; Tolah KMK; Hassan AM; El-Kafrawy SA; Azhar EI
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.
    Yahalom-Ronen Y; Erez N; Fisher M; Tamir H; Politi B; Achdout H; Melamed S; Glinert I; Weiss S; Cohen-Gihon I; Israeli O; Izak M; Mandelboim M; Caraco Y; Madar-Balakirski N; Mechaly A; Shinar E; Zichel R; Cohen D; Beth-Din A; Zvi A; Marcus H; Israely T; Paran N
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
    Ni L; Ye F; Cheng ML; Feng Y; Deng YQ; Zhao H; Wei P; Ge J; Gou M; Li X; Sun L; Cao T; Wang P; Zhou C; Zhang R; Liang P; Guo H; Wang X; Qin CF; Chen F; Dong C
    Immunity; 2020 Jun; 52(6):971-977.e3. PubMed ID: 32413330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
    Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.